The Impact of Communication With Healthcare Providers Via WeChat on Survival Outcomes for Lung Cancer Patietns
NCT ID: NCT06592430
Last Updated: 2024-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
2000 participants
OBSERVATIONAL
2024-10-01
2026-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Supportive Care Mobile Application for Patients With NSCLC
NCT04629300
Improving Patient-reported Outcomes After Lung Cancer Surgery With Mobile Internet Platform
NCT06483295
The Level of Patient Participation in Lung and Esophageal Cancer Patients Treated With Definitive Radiochemotherapy.
NCT06019455
Mobile Health Application of Disease Self-Management in Non-Small Cell Lung Cancer Patients During Targeted Therapy
NCT05611450
Clinician-Patient Communication in Lung Cancer Care
NCT02732834
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients diagnosed with lung cancer use WeChat to communicate with healthcare providers
Patients diagnosed with lung cancer use WeChat to communicate with healthcare providers
Patients diagnosed with lung cancer use WeChat to communicate with healthcare providers
Patients diagnosed with lung cancer don't use WeChat to communicate with healthcare providers
Patients diagnosed with lung cancer don't use WeChat to communicate with healthcare providers
Patients diagnosed with lung cancer don't use WeChat to communicate with healthcare providers
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Patients diagnosed with lung cancer use WeChat to communicate with healthcare providers
Patients diagnosed with lung cancer use WeChat to communicate with healthcare providers
Patients diagnosed with lung cancer don't use WeChat to communicate with healthcare providers
Patients diagnosed with lung cancer don't use WeChat to communicate with healthcare providers
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Pulmonary Hospital, Shanghai, China
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Peng Zhang
Professor
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Wechat-Lung Cancer
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.